The Quebec Semantic Memory Battery: Development, Standardization, and Psychometric Assessment of a Semantic Memory Battery in French
Archives of Clinical Neuropsychology · 2025
DOI: 10.1093/arclin/acae029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical Neuropsychology, 2025. Verfasst von Laura Monetta und 4 weiteren Autor:innen. Beteiligte Einrichtung: École des Sciences de la réadaptation, Faculté de médecine, Université Laval, Québec, QC, Canada. Hauptthemen laut MEDLINE: Psychometrics, Neuropsychological Tests, Semantics, Memory Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer Society of Canada Quality of Life.
Abstract (Originalsprache)
Objective
People with aphasia often experience semantic memory (SM) impairment. To improve diagnostic outcomes, SM tasks should recruit various sensory input channels (oral, written, and pictographic), permitting accessible, complete evaluation. There is a need for SM batteries for French-speaking Quebecers that use multiple input channels. The present study, therefore, describes the development of a novel French-language semantic battery: la Batterie québécoise de la mémoire sémantique (BQMS), the assessment of the BQMS’s psychometric properties, and the establishment of normative data for the BQMS.
Method
We first developed eight SM tasks. Following a pilot validation study, we determined the BQMS’s reliability and validity, to ensure consistent, accurate detection of SM impairment. Among French-speaking Quebecers with cerebrovascular aphasia (n = 10), people with the semantic variant of Primary Progressive Aphasia (n = 4), and healthy controls (n = 14), we examined its convergent validity, concurrent validity, test–retest reliability, and internal consistency. Finally, we established normative data for the BQMS by calculating cut-off scores per task that indicate SM impairment (in 93 cognitively healthy French-speaking Quebecers), stratified by sociodemographic variables associated with performance.
Results
The BQMS shows high concurrent, discriminant, and convergent validity, as well as good test–retest reliability and internal consistency. The cut-off score indicating SM impairment ranged from the 2nd to 25th percentiles (stratified by task, age, and sex).
Conclusions
The BQMS’s psychometric properties indicate that it could be a valuable clinical tool for detecting SM impairment. Our normative data will help clinicians detect such impairments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- École des Sciences de la réadaptation, Faculté de médecine, Université Laval, Québec, QC, Canada.
- Centre interdisciplinaire de recherche en réadaptation, Université Laval, Québec, QC, Canada.
- School of Psychology, University of Ottawa, Ottawa, ON, Canada.
- Centre de recherche CERVO, Brain Research Center, Université Laval, Québec, QC, Canada.
- Bruyère Research Institute, Ottawa, ON, Canada.
ORCID-Profile: Angela Boland
Förderung
- Alzheimer Society of Canada Quality of Life
Zitieren
APA
Monetta, L., Boland, A., Macoir, J., Sheppard, C. L., & Taler, V. (2025). The Quebec Semantic Memory Battery: Development, Standardization, and Psychometric Assessment of a Semantic Memory Battery in French. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acae029
Vancouver
Monetta L, Boland A, Macoir J, Sheppard CL, Taler V. The Quebec Semantic Memory Battery: Development, Standardization, and Psychometric Assessment of a Semantic Memory Battery in French. Archives of Clinical Neuropsychology. 2025. doi:10.1093/arclin/acae029
BibTeX
@article{Monetta2025,
author = {Monetta, Laura and Boland, Angela and Macoir, Joël and Sheppard, Christine L and Taler, Vanessa},
title = {The Quebec Semantic Memory Battery: Development, Standardization, and Psychometric Assessment of a Semantic Memory Battery in French},
journal = {Archives of Clinical Neuropsychology},
year = {2025},
doi = {10.1093/arclin/acae029}
}
EUVIMED